As of 2025-09-18, the EV/EBITDA ratio of Moderna Inc (MRNA) is -3.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNA's latest enterprise value is 8,507.00 mil USD. MRNA's TTM EBITDA according to its financial statements is -2,576.00 mil USD. Dividing these 2 quantities gives us the above MRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.2x - 12.8x | 12.0x |
| Forward P/E multiples | 9.2x - 12.0x | 10.8x |
| Fair Price | (70.75) - (76.31) | (72.51) |
| Upside | -383.0% - -405.3% | -390.0% |
| Date | EV/EBITDA |
| 2025-09-17 | -3.30 |
| 2025-09-16 | -3.28 |
| 2025-09-15 | -3.13 |
| 2025-09-12 | -3.08 |
| 2025-09-11 | -3.36 |
| 2025-09-10 | -3.20 |
| 2025-09-09 | -3.22 |
| 2025-09-08 | -3.28 |
| 2025-09-05 | -3.32 |
| 2025-09-04 | -3.19 |
| 2025-09-03 | -3.16 |
| 2025-09-02 | -3.18 |
| 2025-08-29 | -3.16 |
| 2025-08-28 | -3.22 |
| 2025-08-27 | -3.32 |
| 2025-08-26 | -3.26 |
| 2025-08-25 | -3.36 |
| 2025-08-22 | -3.62 |
| 2025-08-21 | -3.49 |
| 2025-08-20 | -3.59 |
| 2025-08-19 | -3.74 |
| 2025-08-18 | -3.77 |
| 2025-08-15 | -3.76 |
| 2025-08-14 | -3.56 |
| 2025-08-13 | -3.59 |
| 2025-08-12 | -3.40 |
| 2025-08-11 | -3.37 |
| 2025-08-08 | -3.47 |
| 2025-08-07 | -3.55 |
| 2025-08-06 | -3.56 |
| 2025-08-05 | -3.68 |
| 2025-08-04 | -3.70 |
| 2025-08-01 | -3.70 |
| 2025-07-31 | -3.99 |
| 2025-07-30 | -4.38 |
| 2025-07-29 | -4.46 |
| 2025-07-28 | -4.65 |
| 2025-07-25 | -4.68 |
| 2025-07-24 | -4.66 |
| 2025-07-23 | -4.76 |
| 2025-07-22 | -4.47 |
| 2025-07-21 | -4.20 |
| 2025-07-18 | -4.25 |
| 2025-07-17 | -4.39 |
| 2025-07-16 | -4.37 |
| 2025-07-15 | -4.30 |
| 2025-07-14 | -4.49 |
| 2025-07-11 | -4.61 |
| 2025-07-10 | -4.70 |
| 2025-07-09 | -4.48 |